Results 131 to 140 of about 35,587 (239)

Translation and psychometric assessment of the Persian version of the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for the assessment of chemotherapy-induced nausea and vomiting

open access: yes, 2013
No tools are available to assess or measure the experience of chemotherapy-induced nausea and vomiting (CINV) for Persian/Farsi speakers. The purpose of this study is to translate the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for use ...
Shahidsales, S   +17 more
core   +2 more sources

Impact of PD‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background and Aims The optimal sequencing of programmed cell death protein 1 (PD‐1) inhibitors relative to locoregional therapy (LRT) in unresectable hepatocellular carcinoma (uHCC) remains undefined. This study evaluated the impact of PD‐1 inhibitor timing on outcomes in patients receiving hepatic arterial infusion chemotherapy (HAIC) or ...
Jian He   +13 more
wiley   +1 more source

The Efficacy of Pharmacotherapy Intervention on Anthropometric Outcomes in Survivors of Childhood Brain Tumors: An Updated Systematic Review and Meta‐Analysis

open access: yesObesity Reviews, Volume 27, Issue 10, October 2026.
ABSTRACT Introduction Many survivors of childhood brain tumors face long‐term adverse health outcomes like obesity. Uncertainties surround the effect of interventions to manage obesity‐related outcomes in survivors of childhood brain tumors. The goal of this updated systematic review and meta‐analysis was to provide the best estimate of the treatment ...
David Hart   +11 more
wiley   +1 more source

Application of unsupervised learning in clinical oncology practice - exploring anxiety characteristics in chemotherapy-induced nausea and vomiting through principal variables

open access: yes, 2010
State anxiety is a risk factor for chemotherapy-induced nausea and vomiting (CINV). However, anxiety is a subjective symptom and is difficult to quantify in clinical practice. Clinicians need appropriate anxiety measures to assess patients’ risks of CINV.
Yak, Xin Ran   +4 more
core  

Global inequitable distribution of seminal studies of chemotherapy-induced nausea and vomiting. [PDF]

open access: yesSupport Care Cancer
Chai GW   +5 more
europepmc   +1 more source

Marked Bone Marrow Eosinophilia Post‐Azacitidine + Ivosidenib Treatment for Acute Myeloid Leukemia

open access: yes
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 921-923, October 2026.
Christopher Liwski   +2 more
wiley   +1 more source

Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives

open access: yes, 2016
Nellowe Candelario, Marvin Louis Roy Lu Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA Abstract: Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of antineoplastic agents.
Candelario N, Lu MLR
core  

Comparing chemotherapy-induced nausea and vomiting between young adult vs non-young adult cancer patients. [PDF]

open access: yesJNCI Cancer Spectr
Oswald LB   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy